ALSçè縮æ§å´ç´¢ç¡¬åçã®ç¾æ£ã»æ²»çã«é¢ããæ å ±ããã°ã©ã æ¬ãµã¤ãã¯æ¥æ¬å½å ã®ALSæ£è ããããã³ãã®ã家æã対象ã¨ãã¦ãã¾ãã ALSï¼Amyotrophic Lateral Sclerosisï¼ã¯ãæ¥æ¬èªã§çè縮æ§å´ç´¢ç¡¬åçï¼ããããã ãããããããããããããï¼ã¨å¼ã°ããç¥çµã®ç æ°ã§ãé£ç ã®ä¸ã¤ã«æå®ããã¦ãã¾ãã çèã®åããæ¯é ããèé«ã®éåãã¥ã¼ãã³ï¼éåç¥çµç´°èï¼ãä¾µããããããããã ãåããã«ãããªã£ãããçèãããç´°ã£ã¦ãã¾ããç¾å¨ãæ¥æ¬ã«ã¯2016å¹´ã®çµ±è¨ã§ç´9,600人ã®æ£è ããããã¾ãã 詳細ãè¦ã
{{#tags}}- {{label}}
{{/tags}}